Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FN4JT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,485
Award facts
- Contract value 100% obligated
- $15,484.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with a ceiling value of $15,484.65. This competitive award, which carries a firm fixed price and is scheduled for completion by September 16, 2025, was executed without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
As a diabetes management medication, Ozempic falls within the company's extensive portfolio of specialty pharmaceuticals supplied through its federal contracts with DLA and its affiliated agencies. AmerisourceBergen's federal contracting activity demonstrates consistent capability in fulfilling time-sensitive medical supply requirements through competitive procurement processes and firm fixed-price arrangements. The Defense Logistics Agency's reliance on AmerisourceBergen as a prime pharmaceutical vendor reflects the company's established position within the federal medical supply chain and its ability to meet stringent delivery requirements for critical medications supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FN4JT?
SPE2DB25FN4JT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FN4JT worth?
The government has obligated $15,485 on SPE2DB25FN4JT.
Is contract SPE2DB25FN4JT an order under another contract?
Yes. SPE2DB25FN4JT is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN4JT competed?
The extent of competition for SPE2DB25FN4JT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award